Status:
COMPLETED
Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran
Lead Sponsor:
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to: * clarify whether macrophage imaging using ferucarbotran is able to delineate the region of myocardial infarction as accurate as gadolinium-based necrosis/fibrosis imagin...
Eligibility Criteria
Inclusion
- acute myocardial infarction (STEMI or NSTEMI)
Exclusion
- contraindication to CMR or Magnevist® or Resovist®
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00886444
Start Date
March 1 2009
Last Update
November 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert-Bosch-Krankenhaus, Division of Cardiology
Stuttgart, Germany, 70376